Insider transactions

James R Sulat

CIK 1229448 · Former CEO & CFO · last filed 2023-11-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$7.71M
Companies
6
Total Filings
53
Lifetime Open-Market Net
$254.5K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

MNK price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers
MAXYGEN INC — 12 joint filings, latest 2013-07-01
RR Donnelley & Sons Co — 2 joint filings, latest 2004-03-18
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Keenova Therapeutics plc (MNK) Delisted Director 79,399 $0.34 $27.0K $254.5K 5 2023-06-29
XCUR Director — $1.07 — $0 3 2022-06-15
AMAG PHARMACEUTICALS, INC. (AMAG) Delisted Director 0 — — $0 7 2020-11-17
MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Director 54,090 — — $0 17 2019-06-21
CDXS Director 5,957,108 $1.29 $7.71M $0 1 2010-04-29
MEMY President & CEO 0 $14.56 $0 $0 4 2009-01-05

Recent Filings · Page 2 of 6

53 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-11-17 AMAG PHARMACEUTICALS, INC. (AMAG) Delisted Disp (D) −35,090 $0 EDGAR
2020-06-23 — Mixed +454,546 $37.19B
2020-06-04 AMAG PHARMACEUTICALS, INC. (AMAG) Delisted Grant (A) +10,269 $0 EDGAR
2019-12-23 — Grant (A) — $0
2019-06-21 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Mixed +4,356 $0 EDGAR
2019-05-29 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Exer (M) +10,000 $88.5K EDGAR
2019-05-20 AMAG PHARMACEUTICALS, INC. (AMAG) Delisted Grant (A) +8,116 $0 EDGAR
2018-09-10 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Exer (M) +13,500 $199.7K EDGAR
2018-07-20 — Grant (A) +110,000 $0
2018-07-18 — Exer (M) +30,000 $11.1K
Showing 11–20 of 53
Page 2 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.